Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Epigenomics Market Size & Share, By Product (Reagents, Kits, Instruments, Enzymes, Services), Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large non - coding RNA, MicroRNA modification, Chromatin structures), Application (Oncology, Non oncology) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 5668| Published Date: Jan-2025| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Epigenomics Market size is set to increase from USD 16.93 billion in 2024 to USD 70.3 billion by 2034, with a projected CAGR exceeding 15.3% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 19.26 billion.

Base Year Value (2024)
USD 16.93 billion
CAGR (2025-2034)
15.3%
Forecast Year Value (2034)
USD 70.3 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
SNAPSHOT

Epigenomics Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
38% Market Share in 2024
North America: The Epigenomics market size in North America, particularly in the U.S. and Canada, is expected to witness significant growth due to increasing research activities in the field of epigenetics, rising prevalence of cancer and other chronic diseases, and growing investments in personalized medicine. Additionally, favorable government initiatives and supportive reimbursement policies are driving the market growth in this region. 2. Asia Pacific: In Asia Pacific, countries such as China, Japan, and South Korea are expected to experience rapid growth in the Epigenomics market. This growth can be attributed to the increasing focus on precision medicine, rising healthcare expenditure, and advancements in technology. Moreover, the growing prevalence of diseases such as cancer and cardiovascular disorders is boosting the adoption of epigenomic solutions in the region. 3. Europe: The Epigenomics market in Europe, especially in the United Kingdom, Germany, and France, is witnessing steady growth. Factors such as increasing awareness about personalized medicine, rising investments in healthcare infrastructure, and supportive government policies are driving market growth in these countries. Additionally, the presence of prominent market players and ongoing research and development activities are contributing to the market expansion in Europe.
SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report
1. Product Analysis: Reagents, kits, instruments, enzymes, and services are the key products in the epigenomics market. Reagents and kits are essential for conducting epigenetic research, while instruments help in analyzing epigenetic modifications. Enzymes play a crucial role in the modification of DNA and histones, while services offer epigenomic profiling and analysis to researchers and clinicians. 2. Technology Analysis: The epigenomics market utilizes various technologies such as DNA methylation, histone methylation, histone acetylation, large non-coding RNA, microRNA modification, and chromatin structures. Each technology plays a significant role in understanding epigenetic changes and their impact on gene expression. DNA methylation and histone modifications are commonly studied techniques in oncology and non-oncology research. 3. Application Analysis: Oncology and non-oncology are the two main applications of epigenomics research. In oncology, epigenetic modifications have been linked to cancer development, progression, and response to treatment. Non-oncology applications include studying epigenetic changes in neurological disorders, autoimmune diseases, and other non-cancerous conditions. Understanding epigenetic mechanisms in both oncology and non-oncology has the potential to revolutionize personalized medicine and drug development.
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Epigenomics Market is characterized by rapid technological advancements and a growing emphasis on personalized medicine. Companies are focusing on the development of innovative epigenetic therapies and diagnostic tools to address various diseases, particularly cancer and neurological disorders. Collaboration between biotechnology firms, academic institutions, and research organizations is increasing, driving growth and fostering innovation. The market is witnessing a rise in strategic partnerships and mergers, as companies aim to enhance their product portfolios and expand their geographical presence. Additionally, the growing awareness of epigenetic modifications and their implications in health and disease is fueling competition among key players to establish themselves as leaders in this emerging field. Top Market Players - Illumina, Inc. - Thermo Fisher Scientific Inc. - Qiagen N.V. - Roche Holding AG - Novartis AG - Merck KGaA - Active Motif, Inc. - Zymo Research Corp. - HudsonAlpha Institute for Biotechnology - Epigenomics AG
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Epigenomics Market — Custom Segments

Segment Sub-Segment
No segment data available.

Epigenomics Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →